Immune-related adverse events for patients with lung cancer-volume II

被引:0
作者
Wang, Yusha [1 ,2 ]
Wang, Xia [3 ]
Zhan, Cheng [4 ]
Frey, Benjamin [5 ]
Gaipl, Udo S. [5 ]
Shi, Hubing [1 ,2 ]
Ma, Xuelei [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Biotherapy Res, Chengdu, Sichuan, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[5] Dept Radiat Oncol, Univ Klinikum Erlangen, Erlangen, Germany
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
immune-related adverse events (irAEs); immune checkpoint inhibitors (ICIs); Immunotherapy; lung cancer; editorial;
D O I
10.3389/fonc.2023.1282394
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
empty
未找到相关数据